Tyrian, Becton Dickinson End POC TB Dx Partnership

BD and Tyrian ended their partnership to develop a point-of-care diagnostic for active tuberculosis because of an inability to consistently detect Tyrian's lead protein biomarker in clinical samples at high enough sensitivity and specificity levels.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.